Encyclopedia

  • Biliary excretion of taurolithocholate-sulfate and Temocaprilat (cas 110221-53-9) in cholestatic rats induced by bile duct-ligation and ethinylestradiol
  • Add time:08/08/2019         Source:sciencedirect.com

    Down-regulation of multidrug resistance protein 2 (Mrp2), a major canalicular organic anion transporter, has been reported in various cholestatic models and in patients with cholestasis. In the present study, biliary excretion of taurolithocholate-sulfate and Temocaprilat (cas 110221-53-9), substrates of Mrp2, was studied in bile duct-ligated rats and in cholestatic rats induced by ethinylestradiol (EE). Biliary excretion of temocaprilat was more markedly decreased in bile duct-ligated rats than that of taurolithocholate-sulfate. In contrast, biliary excretion of both compounds were similarly inhibited in EE-treated rat. Such difference of the degree of inhibition may have been caused by the different degree of the inhibition of unknown canalicular transporters other than Mrp2 in bile duct-ligated rats.

    We also recommend Trading Suppliers and Manufacturers of Temocaprilat (cas 110221-53-9). Pls Click Website Link as below: cas 110221-53-9 suppliers


    Prev:The effects of temocapril, a new angiotensin converting enzyme inhibitor, on the quality of life in hypertensive patients
    Next: Activation of various subtypes of G-protein α subunits by partial agonists of the adenosine A1 receptor)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View